🧫
Higher midlife p-tau181 levels were associated with increased risk of incident all-cause dementia (HR 1.15 per SD higher).
active
experiment
Created: 2026-04-27T23:22:52
By: etl-v1-backfill
Quality:
50%
✓ SciDEX
ID: exp-f7c22771a114
🧫 Experiment Protocol
ClinicalAlzheimer's diseasehumanextracted
Plasma biomarkers measured using Quanterix Simoa platform from stored specimens; p-tau181 = phosphorylated tau at threonine 181
PRIMARY OUTCOME
Higher midlife p-tau181 levels were associated with increased risk of incident all-cause dementia (HR 1.15 per SD higher).
Source: pmid_39068543
🧫 Experiment Extras
PATHWAY
tau phosphorylation pathway
MARKET PRICE
$0.50
STATUS
extracted
▸Metadataorigin_type: v1_polymorphic_backfill
| origin_type | v1_polymorphic_backfill |
| source_table | experiments |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.